Synapse Medicine provides medication decision solutions to deliver enhanced patient-centered insights for care teams.
At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone.To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey. Synapse is working with world-leading hospitals and digital health companies in the United States, Europe and Japan to transform today’s medication regimens into tomorrow’s medication success.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 1, 2022 | Series B | €25M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mutuelles Impact | — | Series B |